CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 05, 2026 16:00 HKT |  |
|
康哲药业自研INHBE小核酸药物获批超重/肥胖临床
Mar 05, 2026 15:13 HKT |  |
|
康哲藥業自研INHBE小核酸藥物獲批超重/肥胖臨床
Mar 05, 2026 15:02 HKT | |
|
Formerra 任命 Tom Kelly 為首席執行官
Mar 05, 2026 14:11 HKT |  |
|
Formerra Appoints Tom Kelly as Chief Executive Officer
Mar 04, 2026 21:00 HKT | |
|
Formerra 任命 Tom Kelly 为首席执行官
Mar 04, 2026 21:00 HKT | |
|
兩會焦點：腦機接口破圈！從「腦器交互」到產業落地 產學研共啟萬億新賽道
Mar 04, 2026 16:56 HKT | |
|
華領醫藥宣佈多格列艾汀在中國香港獲批上市
Mar 03, 2026 12:51 HKT |  |
|
华领医药宣布多格列艾汀在中国香港获批上市
Mar 03, 2026 12:37 HKT | |
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
Mar 03, 2026 12:14 HKT | |
|
愛康醫療(1789.HK)獲納入中證港股通機器人主題指數 凸顯機器人領域投資潛力
Mar 03, 2026 10:45 HKT |  |
|
爱康医疗(1789.HK)获纳入中证港股通机器人主题指数 凸显机器人领域投资潜力
Mar 03, 2026 10:36 HKT | |
|
天瞳威视IPO观察：营收结构里的非共识 - L2量产"养"出L4落地 意味着什么
Mar 02, 2026 15:42 HKT |  |
|
天瞳威視IPO觀察：營收結構裡的非共識 - L2量產"養"出L4落地 究竟意味著什麼
Mar 02, 2026 15:42 HKT | |
|
君联资本所投企业海致科技在港交所成功上市
Feb 26, 2026 13:08 HKT |  |
|
君聯資本所投企業海致科技在港交所成功上市
Feb 26, 2026 13:08 HKT | |
|
云顶新耀股东特别大会通过商业化服务协议等决议案
Feb 25, 2026 20:59 HKT |  |
|
雲頂新耀股東特別大會通過商業化服務協議等決議案
Feb 25, 2026 20:59 HKT | |
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 25, 2026 19:57 HKT |  |
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT | |
|